Description of Collaborative Activity: |
This workshop was hosted by the FDA in partnership with the National Institute of Allergy and Infectious Diseases (NIAID), the HHS Office of the Assistant Secretary for Preparedness and Response (ASPR), and the CDC.This workshop explored the ethical and methodological assumptions behind the choice of different trial designs, described different types of emerging infectious diseases of concern, and then explored several clinical trial designs for both vaccines and therapeutic products. Participants discussed the scientific, ethical, and practical issues considered in the choice of specific trial designs, and the generalizability of these designs for other types of emerging infectious diseases. |
